APRIL 15, 2011 MARKED a special mo-
ment in the political history of the premium
cigar industry. It was the day U.S. Congress-
man Bill Posey of Florida filed the Tradition-
al Cigar Manufacturing and Small Business
Jobs Preservation Act for the first time. It was
a spring day, almost five years ago to the day
as I write this. He has done so now for four
sessions of Congress.
What makes this act so unique is not just its
purpose of protecting premium handmade ci-
gars from draconian regulations proposed by
the U.S. Food & Drug Administration, and not
just to dramatize how the agency went well
beyond Congressional intent in advancing
the rule. It was that the very filing of the act
marked the first time the premium cigar indus-
try went on political offense.
Normally, and historically, the industry
had to react to legislative threats. These
ranged from local and state tax and smoking
ban measures to the tax proposal to fund the
federal State Childrenʼs Health Insurance
Program (SCHIP), which served as an indus-
try wake-up call.
April 15, 2011 was different. It was the day
premium cigar makers said, “We are different.
We don’t deserve what they’re planning—and
we’re not taking it lying down. It’s time to
make our case.”
Since that day, 289 different members of the
U.S. House of Representatives and 28 mem-
bers of the U.S. Senate have signed legislation
calling for an exemption for premium hand-
made cigars that meet a strict definition (over
60 of whom voted for the original Tobacco
Control Act). More than 35 letters, either from
individual members or joint letters, proclaim-
ing support for this position have been sent to
the former Administration, the new Admin-
istration and to multiple agencies within the
federal government.
But what has been the result? Foes of this
strategy say “not much,” questioning the ex-
pense and time into the effort. I beg to differ
for one major reason—it created a standing
record of legislators upon which to build a
network of advocates that now know that we
are different. This network can work to ad-
dress issues well into the future, and can assist
in conveying the serious concerns the industry
has with the FDA regulatory process.
Without the process and strategy that has
been executed over the last five years, we
would not have known that the current Vice
President of the United States, U.S. Secre-
tary of Health & Human Services and White
House Director of the Office of Management
& Budget could be allies, by virtue of signing
onto this legislation during their service in the
House of Representatives. Without the strat-
egy of the last five years, we would not have
known that Democrats and Republicans alike
could come together not on a “tobacco bill,”
but on a bill that has enabled the industry to
articulate its small business, family-driven,
artistic and cultural foundations.
This process has compelled the industry to
also take a deeper look at itself. It has allowed
for the accumulation of information virtually
unrealized before on the economic signifi-
cance of the sector, especially in key states such
as Florida, Pennsylvania, Connecticut, Louisi-
ana and Nevada, and the base of brand own-
ers that are incorporated in California, Texas,
New Jersey, Kentucky and Virginia.
It has allowed for the building of coali-
tions nonexistent before that April day of
2011, with special interests never before ap-
proached by the industry for political support
ranging from chambers of commerce, retail
merchants organizations, local governments,
mayors, farmers, ports and truckers, just to
name a few.
Conveying the threat of the regulations to
members of Congress has also allowed for the
discussion on the economic significance of the
industry in the very economically and politi-
cally fragile region of Latin America, where
investment and employment by the industry
directly contributes to stability of governments
and families alike.
Stories have long circulated about the ef-
fort to mitigate the threat of the SCHIP taxes.
Rocky Patel and Jeff Borysiewicz have stated
that they hit the halls of Congress, “talking to
anyone willing to listen.” It’s come a long way
since 2007.
Now, language has been included in four
appropriations measures in the U.S. House
of Representatives proclaiming that premium
cigars are unique and that they are not what
Congress intended when addressing tobacco
control. In April of 2016, the House actual-
ly said, “None of these funds made available
may be used to finalize, implement, admin-
ister or enforce the proposed rule…if such
rule applies to traditional large and premium
cigars.” That’s progress: Now we just have
to get it through the Senate and off to The
White House.
There are legislative measures that take
years to work through the process, if you can
call it that. Recently I had that discussion with
some advocates for other causes—covering the
elimination of the “death tax” and regulations
on the energy sector, as well as the eternal
debates on health care, education and tax re-
form. Premium cigars are now in that mix.
It all goes back to the proverbial Washington
statement, “If you’re not at the table, you’re on
the menu.” Now that the premium cigar sector
has a standing presence in the halls of Con-
gress, it will always be “at the table.”
The issue is patience. The level of nervous-
ness and anticipation within the industry due
to the impending rules is quite understand-
able. However, 2017 represents the most deci-
sive moment since this journey began to pro-
tect this industry from the heavy hand of an
unsympathetic bureaucracy.
Whether through the Administration, Con-
gress or the courts, the virtue of a five-year leg-
islative and advocacy movement will hopefully
prove to be a most wise investment.
TB
CRA CORNER
[ GLYNN LOOPE ]
[ 10 ]
TOBACCO BUSINESS
[
MAY
/
JUNE
|
17 ]
The Virtue of a
Legislative Record
Glynn Loope is
executive director
of Cigar Rights
of America.